DK318689A - Anvendelse af lactamimider til fremstilling af calcium-antagonister - Google Patents

Anvendelse af lactamimider til fremstilling af calcium-antagonister Download PDF

Info

Publication number
DK318689A
DK318689A DK318689A DK318689A DK318689A DK 318689 A DK318689 A DK 318689A DK 318689 A DK318689 A DK 318689A DK 318689 A DK318689 A DK 318689A DK 318689 A DK318689 A DK 318689A
Authority
DK
Denmark
Prior art keywords
lactamimides
preparation
calcium antagonists
antagonists
calcium
Prior art date
Application number
DK318689A
Other languages
English (en)
Other versions
DK318689D0 (da
Inventor
Michael G Palfreyman
Hsien C Cheng
Norbert L Wiech
John M Kane
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK318689D0 publication Critical patent/DK318689D0/da
Publication of DK318689A publication Critical patent/DK318689A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK318689A 1988-06-28 1989-06-27 Anvendelse af lactamimider til fremstilling af calcium-antagonister DK318689A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/212,544 US5010072A (en) 1988-06-28 1988-06-28 Lactamimides as calcium antagonists

Publications (2)

Publication Number Publication Date
DK318689D0 DK318689D0 (da) 1989-06-27
DK318689A true DK318689A (da) 1989-12-29

Family

ID=22791465

Family Applications (1)

Application Number Title Priority Date Filing Date
DK318689A DK318689A (da) 1988-06-28 1989-06-27 Anvendelse af lactamimider til fremstilling af calcium-antagonister

Country Status (8)

Country Link
US (1) US5010072A (da)
EP (1) EP0348891A3 (da)
JP (1) JPH0253725A (da)
KR (1) KR900000083A (da)
AU (1) AU619310B2 (da)
DK (1) DK318689A (da)
PH (1) PH26115A (da)
ZA (1) ZA894755B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990048801A (ko) * 1997-12-10 1999-07-05 차동천 유기성 폐기물의 발효 처리장치 및 그 처리방법
KR102648928B1 (ko) * 2020-07-20 2024-03-18 임주연 가축분뇨의 퇴비화 방법 및 장치
KR102318901B1 (ko) * 2021-04-29 2021-10-28 정종균 퇴비 발효 종균 분배기

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH412463A (de) * 1962-07-10 1966-04-30 Geigy Ag J R Fungizides Mittel
US3873520A (en) * 1971-05-13 1975-03-25 Richardson Merrell Inc 9-Fluorenyl lactamimides
US3894002A (en) * 1971-05-13 1975-07-08 Richardson Merrell Inc Substituted naphthylalkylene lactamimides
US3881006A (en) * 1971-09-13 1975-04-29 Richardson Merrell Inc Hypoglycemic compositions containing benzhydryllactamimide derivatives
BE788767A (fr) * 1971-09-13 1973-01-02 Richardson Merrell Inc Compositions hypoglycemiques contenant des derives de benzhydryllactamimide
US3900565A (en) * 1971-09-13 1975-08-19 Richardson Merrell Inc Hypoglycemic compositions containing benzhydryllactamimide derivatives
US3838851A (en) * 1972-02-22 1974-10-01 Addressograph Multigraph Bottom sheet feeder
US3852269A (en) * 1972-04-18 1974-12-03 Richardson Merrell Inc Diphenylalkyllactamimide derivatives
US3838151A (en) * 1972-08-11 1974-09-24 Richardson Merrell Inc Cycloalkyllactamimides
US3803170A (en) * 1972-08-11 1974-04-09 Richardson Merrell Inc 2-((1-benzylcyclopentyl)imino)pyrrolidine
US3833559A (en) * 1973-01-05 1974-09-03 Richardson Merrell Inc Dibenzocycloheptenyl lactamimides
US3816457A (en) * 1973-01-05 1974-06-11 Richardson Merrell Inc Lactamimide derivatives
US3890445A (en) * 1973-01-05 1975-06-17 Richardson Merrell Inc Lactamimide derivatives useful as hypoglycemic agents
US3845071A (en) * 1973-03-12 1974-10-29 Richardson Merrell Inc Imidazo(1,2-a)azacycloalkanes
US3840524A (en) * 1973-04-25 1974-10-08 Richardson Merrell Inc Alpha-cycloalkylbenzyl lactamimides
US3840523A (en) * 1973-04-25 1974-10-08 Richardson Merrell Inc Tricyclic arylalkylene lactamimides
US4055561A (en) * 1973-04-25 1977-10-25 Richardson-Merrell Inc. α-Alkylbenzyl lactamimides

Also Published As

Publication number Publication date
AU619310B2 (en) 1992-01-23
JPH0253725A (ja) 1990-02-22
EP0348891A2 (en) 1990-01-03
PH26115A (en) 1992-02-24
KR900000083A (ko) 1990-01-30
EP0348891A3 (en) 1991-05-15
ZA894755B (en) 1990-03-28
DK318689D0 (da) 1989-06-27
US5010072A (en) 1991-04-23
AU3712289A (en) 1990-01-04

Similar Documents

Publication Publication Date Title
DK36491D0 (da) Praeparat til behandling af erektiv dysfunktion
DK453789D0 (da) Fremgangsmaade til paavirkning af azopigmenters triboelektriske effekt
DK289189A (da) Fremgangsmaade til fremstilling af saccharosepolyestere
DK665489A (da) Fremgangsmaade til fremstilling af mono-n-alkylerede polyazamakrocykliske forbindelser
DK140789A (da) Overfladesamlingsorganer til fremstilling af betonindsproejtningsforskallinger
DK250689D0 (da) Fremgangsmaade til fremstilling af napthalenderivater
DK495089D0 (da) Anvendelse af thromboxan a2-receptor-antagonister til fremstilling af laegemidler
DK100289A (da) Fremgangsmaade til fremstilling af n-sulfonylurinstoffer
DK309789D0 (da) Fremgangsmaade til fremstilling af alumoxaner
DK601489A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK115291D0 (da) Fremgangsmaade til fremstilling af amfotere overfladeaktive imidazolinderivater
DK112089A (da) Fremgangsmaade til fremstilling af jordalkalimetaltitanater
DK245590D0 (da) Fremgangsmaade til fremstilling af asfaltblandinger
DK315789D0 (da) Fremgangsmaade til fremstilling af halogenerede sulfoner
DK318689D0 (da) Anvendelse af lactamimider til fremstilling af calcium-antagonister
DK53787D0 (da) Fremgangsmaade til fremstilling af carboxylsyreamider
DK143889A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK293589D0 (da) Fremgangsmaade til fremstiling af lactolderivater
DK533287A (da) Fremgangsmaade til fremstilling af azetidinoner
DK184789A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK184687D0 (da) Fremgangsmaade til fremstilling af diacetonesorbose
DK9090A (da) Fremgangsmaade til fremstilling af calciumsulfat-alfa-hemihydrat samt anvendelse af dette
DK162789D0 (da) Fremgangsmaade til fremstilling af alkalimetalphenylpyruvat
DK278790A (da) Indretning til forskydning af jernbanevogne
DK127589D0 (da) Fremgangsmaade til fremstilling af phenolskumstoffer

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment